Patients with multiple sclerosis (MS) treated with alemtuzumab show sustained reduction in relapses and disability after five years, according to results reported at the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) annual meeting (14 October; Gothenburg, Sweden). The CAMMS223 study randomised 334 patients with early, active relapsing remitting MS to alemtuzumab (at… Continue reading
Tag: multiple sclerosis
Multiple sclerosis – immune cells attack neurons directly
Researchers in Germany have gained new insight into how the immune system causes damage associated with multiple sclerosis (MS), an incurable neuroinflammatory disorder. Using imaging tools which enable investigation of processes in living organisms, they were able to show a direct interaction between immune cells and neurons which plays a significant role in neuronal injury.… Continue reading
New View Of Multiple Sclerosis from imaging study
Scientists have uncovered an alternative source for some of the damage associated with multiple sclerosis (MS), an incurable neuroinflammatory disorder. The research, published online by Cell Press on September 23rd in the journal Immunity, reveals a direct interaction between immune cells and neurons that plays a significant role in neuronal injury and may respond to… Continue reading
High risk of multiple sclerosis from eating of margarine, procesed meat and other foods
Increased production of certain types of industrially produced foods – specifically of margarine, processed meat and sausage, jam and marmalade, chocolate and chocolate confectionary, sugar confectionary and beer – correlates statistically with an increased incidence of multiple sclerosis (MS). This conclusion from analysis of data from seven EU countries is presented today by the German… Continue reading
New ways to reverse the damages from multiple sclerosis
A National Institutes of Health grant will help University of Central Florida researchers explore new ways to potentially reverse the damage caused by multiple sclerosis and other neurological disorders. Stephen Lambert, an associate professor in the College of Medicine and a member of UCF’s Hybrid Systems Laboratory, has received $428,000, the first installment of a… Continue reading
New serum DNA Assays can monitor disease activity and treatment response in multiple sclerosis
Chronix Biomedical announced publication of a study that supports the utility of its serum DNA blood tests to predict clinical status and monitor disease activity and response to treatment in multiple sclerosis (MS). Chronix Biomedical uses proprietary technology to identify disease-specific genetic fingerprints based on the circulating DNA that is released into the bloodstream by… Continue reading